Imported Disease Annotations - CTDTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | polycystic ovary syndrome | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:21411543 | |
|
Imported Disease Annotations - CTDTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | polycystic ovary syndrome | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:21411543 | |
|
|
|
|
|
|
|
|
|
|
# | Reference Title | Reference Citation |
1. | GOAs Human GO annotations | GOA_HUMAN data from the GO Consortium |
2. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
PMID:172504 | PMID:1371113 | PMID:2422163 | PMID:2424697 | PMID:2452822 | PMID:2468994 | PMID:2536708 | PMID:2611225 | PMID:2708337 | PMID:6194155 | PMID:6204923 | PMID:6209613 |
PMID:6319099 | PMID:6690982 | PMID:7922031 | PMID:8202136 | PMID:9012484 | PMID:9578495 | PMID:10373373 | PMID:11893904 | PMID:12477932 | PMID:12511603 | PMID:12914533 | PMID:14715707 |
PMID:15217983 | PMID:15253136 | PMID:15285305 | PMID:15299093 | PMID:15309632 | PMID:17510243 | PMID:18606016 | PMID:18782867 | PMID:19002615 | PMID:19047151 | PMID:19173346 | PMID:20716560 |
PMID:20734064 | PMID:20962020 | PMID:21167905 | PMID:22554618 | PMID:22769733 | PMID:23499152 | PMID:23510993 | PMID:23812658 | PMID:25064170 | PMID:25193288 | PMID:25300619 | PMID:25456363 |
PMID:26968839 | PMID:28093002 | PMID:29997244 | PMID:32296183 | PMID:34373451 | PMID:35156780 | PMID:35624327 | PMID:37062114 | PMID:38214358 | PMID:38270320 |
.
Variants in CGB5
10 total Variants |
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 19q13.32-13.33(chr19:46658791-49050450)x3 | copy number gain | See cases [RCV000052913] | Chr19:46658791..49050450 [GRCh38] Chr19:47162048..49553707 [GRCh37] Chr19:51853888..54245519 [NCBI36] Chr19:19q13.32-13.33 |
pathogenic |
GRCh38/hg38 19q13.33-13.43(chr19:47908540-58539965)x3 | copy number gain | See cases [RCV000052914] | Chr19:47908540..58539965 [GRCh38] Chr19:48411797..59051332 [GRCh37] Chr19:53103609..63743144 [NCBI36] Chr19:19q13.33-13.43 |
pathogenic |
GRCh38/hg38 19q13.33-13.43(chr19:47929575-58572206)x3 | copy number gain | See cases [RCV000052915] | Chr19:47929575..58572206 [GRCh38] Chr19:48432832..59083573 [GRCh37] Chr19:53124644..63775385 [NCBI36] Chr19:19q13.33-13.43 |
pathogenic |
GRCh37/hg19 19q13.33(chr19:49519850-49558959)x3 | copy number gain | See cases [RCV000447118] | Chr19:49519850..49558959 [GRCh37] Chr19:19q13.33 |
benign |
GRCh37/hg19 19p13.3-q13.43(chr19:260912-58956888) | copy number gain | See cases [RCV000512296] | Chr19:260912..58956888 [GRCh37] Chr19:19p13.3-q13.43 |
pathogenic |
GRCh37/hg19 19p13.3-q13.43(chr19:260912-58956888)x3 | copy number gain | See cases [RCV000511289] | Chr19:260912..58956888 [GRCh37] Chr19:19p13.3-q13.43 |
pathogenic|uncertain significance |
GRCh37/hg19 19p13.3-q13.43(chr19:68029-59110290)x3 | copy number gain | not provided [RCV000752439] | Chr19:68029..59110290 [GRCh37] Chr19:19p13.3-q13.43 |
pathogenic |
GRCh37/hg19 19p13.3-q13.43(chr19:260912-59097160)x3 | copy number gain | not provided [RCV000752444] | Chr19:260912..59097160 [GRCh37] Chr19:19p13.3-q13.43 |
pathogenic |
NM_033043.2(CGB5):c.72G>A (p.Pro24=) | single nucleotide variant | not provided [RCV000949074] | Chr19:49044633 [GRCh38] Chr19:49547890 [GRCh37] Chr19:19q13.33 |
benign |
NM_033043.2(CGB5):c.306C>T (p.Tyr102=) | single nucleotide variant | not provided [RCV000949075] | Chr19:49045102 [GRCh38] Chr19:49548359 [GRCh37] Chr19:19q13.33 |
likely benign |
GRCh37/hg19 19q13.33(chr19:48119589-49595956)x3 | copy number gain | not provided [RCV000848800] | Chr19:48119589..49595956 [GRCh37] Chr19:19q13.33 |
uncertain significance |
GRCh37/hg19 19q13.32-13.42(chr19:47939842-54626871) | copy number gain | not provided [RCV001249294] | Chr19:47939842..54626871 [GRCh37] Chr19:19q13.32-13.42 |
not provided |
GRCh37/hg19 19q13.31-13.42(chr19:44738088-53621561)x3 | copy number gain | not provided [RCV001007050] | Chr19:44738088..53621561 [GRCh37] Chr19:19q13.31-13.42 |
pathogenic |
GRCh37/hg19 19q13.33-13.43(chr19:48463931-57095254)x3 | copy number gain | not provided [RCV001259944] | Chr19:48463931..57095254 [GRCh37] Chr19:19q13.33-13.43 |
pathogenic |
NC_000019.9:g.(?_49519325)_(50366015_?)dup | duplication | Developmental and epileptic encephalopathy, 12 [RCV002030046] | Chr19:49519325..50366015 [GRCh37] Chr19:19q13.33 |
uncertain significance |
NC_000019.9:g.(?_48618906)_(50921204_?)dup | duplication | Developmental and epileptic encephalopathy, 12 [RCV001939968]|not provided [RCV001916178] | Chr19:48618906..50921204 [GRCh37] Chr19:19q13.33 |
uncertain significance |
NC_000019.9:g.(?_49472545)_(49714755_?)del | deletion | Progressive familial heart block type IB [RCV003119771] | Chr19:49472545..49714755 [GRCh37] Chr19:19q13.33 |
uncertain significance |
NM_033043.2(CGB5):c.415T>C (p.Ser139Pro) | single nucleotide variant | Inborn genetic diseases [RCV002689055] | Chr19:49045211 [GRCh38] Chr19:49548468 [GRCh37] Chr19:19q13.33 |
uncertain significance |
NM_033043.2(CGB5):c.272G>T (p.Gly91Val) | single nucleotide variant | Inborn genetic diseases [RCV002799945] | Chr19:49045068 [GRCh38] Chr19:49548325 [GRCh37] Chr19:19q13.33 |
uncertain significance |
NM_033043.2(CGB5):c.227T>C (p.Val76Ala) | single nucleotide variant | Inborn genetic diseases [RCV002758531] | Chr19:49045023 [GRCh38] Chr19:49548280 [GRCh37] Chr19:19q13.33 |
uncertain significance |
NM_033043.2(CGB5):c.396C>G (p.Asp132Glu) | single nucleotide variant | Inborn genetic diseases [RCV002989314] | Chr19:49045192 [GRCh38] Chr19:49548449 [GRCh37] Chr19:19q13.33 |
uncertain significance |
NM_033043.2(CGB5):c.182T>G (p.Met61Arg) | single nucleotide variant | Inborn genetic diseases [RCV003279515] | Chr19:49044743 [GRCh38] Chr19:49548000 [GRCh37] Chr19:19q13.33 |
uncertain significance |
NM_033043.2(CGB5):c.428C>G (p.Ala143Gly) | single nucleotide variant | Inborn genetic diseases [RCV003175431] | Chr19:49045224 [GRCh38] Chr19:49548481 [GRCh37] Chr19:19q13.33 |
uncertain significance |
NM_033043.2(CGB5):c.65A>G (p.Lys22Arg) | single nucleotide variant | Inborn genetic diseases [RCV003173755] | Chr19:49044626 [GRCh38] Chr19:49547883 [GRCh37] Chr19:19q13.33 |
likely benign |
NM_033043.2(CGB5):c.441C>G (p.Ser147Arg) | single nucleotide variant | Inborn genetic diseases [RCV003174895] | Chr19:49045237 [GRCh38] Chr19:49548494 [GRCh37] Chr19:19q13.33 |
uncertain significance |
GRCh37/hg19 19q13.33-13.41(chr19:48905537-51614930)x3 | copy number gain | not specified [RCV003986127] | Chr19:48905537..51614930 [GRCh37] Chr19:19q13.33-13.41 |
likely pathogenic |
The detailed report is available here: | Full Report | CSV | TAB | Printer | ||||
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
STS-J00117 |
|
||||||||||||||||||||
RH71426 |
|
||||||||||||||||||||
D19S1130 |
|
||||||||||||||||||||
UniSTS:483811 |
|
alimentary part of gastrointestinal system | circulatory system | endocrine system | exocrine system | hemolymphoid system | hepatobiliary system | integumental system | musculoskeletal system | nervous system | renal system | reproductive system | respiratory system | sensory system | adipose tissue | appendage | |
High | |||||||||||||||
Medium | |||||||||||||||
Low | 21 | 1 | 219 | 1 | 105 | 8 | 215 | 1 | 387 | 11 | 62 | ||||
Below cutoff | 1133 | 1176 | 1151 | 231 | 577 | 73 | 3431 | 1229 | 1887 | 97 | 1293 | 1061 | 158 | 802 | 2203 |
RefSeq Acc Id: | ENST00000301408 ⟹ ENSP00000301408 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NM_033043 ⟹ NP_149032 | ||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NP_149032 ⟸ NM_033043 |
- Peptide Label: | precursor |
- UniProtKB: | Q8WXL3 (UniProtKB/Swiss-Prot), Q8WXL2 (UniProtKB/Swiss-Prot), Q8WXL1 (UniProtKB/Swiss-Prot), Q8WTT5 (UniProtKB/Swiss-Prot), Q3SY41 (UniProtKB/Swiss-Prot), Q3KPI3 (UniProtKB/Swiss-Prot), Q14000 (UniProtKB/Swiss-Prot), Q13991 (UniProtKB/Swiss-Prot), P01233 (UniProtKB/Swiss-Prot), B9ZVP5 (UniProtKB/Swiss-Prot), A1A5E0 (UniProtKB/Swiss-Prot), Q8WXL4 (UniProtKB/Swiss-Prot), P0DN86 (UniProtKB/Swiss-Prot), A0A0F7RQP8 (UniProtKB/TrEMBL), A0A0F7RPU2 (UniProtKB/TrEMBL) |
- Sequence: |
RefSeq Acc Id: | ENSP00000301408 ⟸ ENST00000301408 |
Name | Modeler | Protein Id | AA Range | Protein Structure |
AF-P0DN86-F1-model_v2 | AlphaFold | P0DN86 | 1-165 | view protein structure |
RGD ID: | 13205065 | ||||||||
Promoter ID: | EPDNEW_H26113 | ||||||||
Type: | initiation region | ||||||||
Name: | CGB5_3 | ||||||||
Description: | chorionic gonadotropin beta subunit 5 | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Alternative Promoters: | null; see alsoEPDNEW_H26108 EPDNEW_H26114 | ||||||||
Experiment Methods: | Single-end sequencing.; Paired-end sequencing. | ||||||||
Position: |
|
RGD ID: | 13205067 | ||||||||
Promoter ID: | EPDNEW_H26114 | ||||||||
Type: | multiple initiation site | ||||||||
Name: | CGB5_1 | ||||||||
Description: | chorionic gonadotropin beta subunit 5 | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Alternative Promoters: | null; see alsoEPDNEW_H26108 EPDNEW_H26113 | ||||||||
Experiment Methods: | Single-end sequencing.; Paired-end sequencing. | ||||||||
Position: |
|
RGD ID: | 6850004 | ||||||||
Promoter ID: | EP11129 | ||||||||
Type: | single initiation site | ||||||||
Name: | HS_CGB | ||||||||
Description: | Chorionic gonadotropin-beta, CGB gene. | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPD (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Tissues & Cell Lines: | placenta | ||||||||
Experiment Methods: | Nuclease protection; Primer extension | ||||||||
Position: |
|
Database | Acc Id | Source(s) |
AGR Gene | HGNC:16452 | AgrOrtholog |
COSMIC | CGB5 | COSMIC |
Ensembl Genes | ENSG00000104827 | UniProtKB/Swiss-Prot |
ENSG00000189052 | Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot | |
ENSG00000213030 | UniProtKB/Swiss-Prot | |
Ensembl Transcript | ENST00000301408 | ENTREZGENE |
ENST00000301408.7 | UniProtKB/Swiss-Prot | |
ENST00000357383.4 | UniProtKB/Swiss-Prot | |
ENST00000448456.4 | UniProtKB/Swiss-Prot | |
Gene3D-CATH | 2.10.90.10 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
GTEx | ENSG00000104827 | GTEx |
ENSG00000189052 | GTEx | |
ENSG00000213030 | GTEx | |
HGNC ID | HGNC:16452 | ENTREZGENE |
Human Proteome Map | CGB5 | Human Proteome Map |
InterPro | Cystine-knot_cytokine | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
Glyco_hormone_CN | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Gonadotropin_bsu | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Gonadotropin_bsu_CS | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
KEGG Report | hsa:1082 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
hsa:93659 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
hsa:94115 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
NCBI Gene | 93659 | ENTREZGENE |
OMIM | 608825 | OMIM |
PANTHER | LUTROPIN SUBUNIT BETA | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
PTHR11515 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Pfam | Cys_knot | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
PharmGKB | PA26437 | PharmGKB |
PROSITE | GLYCO_HORMONE_BETA_1 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
GLYCO_HORMONE_BETA_2 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
SMART | GHB | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
Superfamily-SCOP | SSF57501 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
UniProt | A0A0F7RPU2 | ENTREZGENE, UniProtKB/TrEMBL |
A0A0F7RQP8 | ENTREZGENE, UniProtKB/TrEMBL | |
A1A5E0 | ENTREZGENE | |
B9ZVP5 | ENTREZGENE | |
CGB3_HUMAN | UniProtKB/Swiss-Prot | |
P01233 | ENTREZGENE | |
P0DN86 | ENTREZGENE | |
Q13991 | ENTREZGENE | |
Q14000 | ENTREZGENE | |
Q3KPI3 | ENTREZGENE | |
Q3SY41 | ENTREZGENE | |
Q8WTT5 | ENTREZGENE | |
Q8WXL1 | ENTREZGENE | |
Q8WXL2 | ENTREZGENE | |
Q8WXL3 | ENTREZGENE | |
Q8WXL4 | ENTREZGENE | |
UniProt Secondary | A1A5E0 | UniProtKB/Swiss-Prot |
B9ZVP5 | UniProtKB/Swiss-Prot | |
P01233 | UniProtKB/Swiss-Prot | |
Q13991 | UniProtKB/Swiss-Prot | |
Q14000 | UniProtKB/Swiss-Prot | |
Q3KPI3 | UniProtKB/Swiss-Prot | |
Q3SY41 | UniProtKB/Swiss-Prot | |
Q8WTT5 | UniProtKB/Swiss-Prot | |
Q8WXL1 | UniProtKB/Swiss-Prot | |
Q8WXL2 | UniProtKB/Swiss-Prot | |
Q8WXL3 | UniProtKB/Swiss-Prot | |
Q8WXL4 | UniProtKB/Swiss-Prot |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2018-05-01 | CGB5 | chorionic gonadotropin subunit beta 5 | CGB5 | chorionic gonadotropin beta subunit 5 | Symbol and/or name change | 5135510 | APPROVED |
2016-01-19 | CGB5 | chorionic gonadotropin beta subunit 5 | CGB5 | chorionic gonadotropin, beta polypeptide 5 | Symbol and/or name change | 5135510 | APPROVED |